Skip to main content

Table 8 Temporal trends of antimicrobial resistance in Proteus spp. by country

From: European multicenter study on antimicrobial resistance in bacteria isolated from companion animal urinary tract infections

Countrya
(Years)
AMC FLU SXT
ORb (95 % CI)c
P value
ORb (95 % CI) c
P value
ORb (95 % CI) c
P value
BE (2010–13) 0.627 (0.312–1.259)
0.1889
1.292 (1.0061.659)
0.0450
0.891 (0.726–1.092)
0.2649
FR (2010–13) 0.945 (0.625–1.431)
0.7908
1.004 (0.764–1.319)
0.9770
0.954 (0.756–1.205)
0.6944
NL (2008–13) 1.092 (0.860–1.387)
0.4709
0.970 (0.829–1.135)
0.7067
1.010 (0.903–1.129)
0.8660
SE (2008–13) 0.892 (0.657–1.210)
0.4620
0.884 (0.494–1.583)
0.6788
0.941 (0.759–1.165)
0.5756
  1. AMC amoxicillin clavulanate, FLU fluoroquinolones, SXT trimethoprim/sulfamethoxazole
  2. Statistically significant trends are highlighted in bold
  3. aBE, Belgium; DK, Denmark; FR, France; NL, the Netherlands; SE, Sweden; CH, Switzerland
  4. bOR, Odds ratio
  5. c95 % CI, 95 % Confidence interval